Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease
NCT: NCT05192057 · RECRUITING
Brief Summary
The SALINE trial will investigate the effect of Hypertonic Saline inhalation plus best supportive care on burden of symptoms, clearance of mycobacteria and functional capacities in participants with Mycobacterium avium complex lung disease and compare the effect to treatment with best supportive care alone.
Frequently Asked Questions
What is Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease?
Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease is a clinical trial registered under NCT05192057. Current status: RECRUITING.
What is the status of NCT05192057?
The current status of NCT05192057 (Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease) is: RECRUITING.
When did Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease start?
Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease started on 2022-05-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.